ELISA Kit for Advanced Glycation End Product (AGE) View larger

ELISA Kit for Advanced Glycation End Product (AGE)

CC-CEB353Ge

New product

48T, 96T, 96T×5, 96T×10, 96T×100

More details

Registe-se for viewing this price!

Ao comprar este produto pode ganhar até 7 pontos de fidelização. Seu carrinho totalizará 7 pontos de fidelização que podem ser convertidos num vale de desconto de 28.00EUR.


Data sheet

Size 96T
Storage Conditions -20°C
Shipping Conditions Entre 4°C y 8°C
Applications Enzyme-linked immunosorbent assay for Antigen Detection.
Detection Range 98.8-8,000ng/mL
Sensitivity The minimum detectable dose of this kit is typically less than 38.2ng/mL
Research Area Metabolic pathway
Organism species Pan-species (General)
Alternative Names AGEs
Item Name Advanced Glycation End Product
Assay Length 2h
Method Competitive Inhibition
Sample Type serum, plasma and other biological fluids
Formato 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100
Test Principle This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Advanced Glycation End Product (AGE) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled
Assay procedure summary 1. Prepare all reagents, samples and standards
UniProt ID -

More info

Click here for manual in PDF

Click here for OD Image


CITATIONS
Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM);A long-standing hyperglycaemic condition impairs skin barrier by accelerating skin ageing process;Daily intake of vitamin D- or calcium-vitamin D-fortified Persian yogurt drink (doogh) attenuates diabetes-induced oxidative stress: evidence for antioxidative properties of vitamin D.;Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.;Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus.;Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications;Nitroxides prevent protein glycoxidation in vitro.;Serum advanced glycation end products are associated with insulin resistance in male nondiabetic patients with obstructive sleep apnea;Ascorbic acid and protein glycation;Establishment of a rabbit model to study the influence of advanced glycation end products accumulation on osteoarthritis and the protective effect of pioglitazone;Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea;Glycation of bovine serum albumin by ascorbate;Impact of morbid obesity and bariatric surgery on antioxidant/oxidant balance of the unstimulated and stimulated human saliva;Inhibition of Advanced Glycation Endproduct Formation by Lotus Seedpod Oligomeric Procyanidins through RAGE-MAPK Signaling and NF-κB Activation in High-Fat-Diet Rats.;ADVANCED GLYCATION END PRODUCTS'RESPONSE TO RESISTANCE TRAINING IN POSTMENOPAUSAL WOMEN WITH TYPE II DIABETES;Effects of edible bird's nest on hippocampal and cortical neurodegeneration in ovariectomized rats;Beneficial effects of urine-derived stem cells on fibrosis and apoptosis of myocardial, glomerular and bladder cells;Effects of S-Nitroso-N-Acetyl-Penicillamine (SNAP) on Inflammation, Lung Tissue Apoptosis and iNOS Activity in a Rabbit Model of Acute Lung Injury;The Receptor for Advanced Glycation End Products (Rage) and Its Ligands in Plasma and InfrainCavia (Guinea pig )inal Bypass Vein;Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.;Inhibition of Methylglyoxal-Induced AGEs/RAGE Expression Contributes to Dermal Protection by N-Acetyl-L-Cysteine.;Glutathione is the main endogenous inhibitor of protein glycation.;Establishment of a rabbit model to study the influence of advanced glycation end productsaccumulation on osteoarthritis and the protective effect of pioglitazone.;Advanced glycation end products promote VEGF expression and thus choroidal neovascularization via Cyr61-PI3K/AKT signaling pathway;Lychee seed extract protects against neuronal injury and improves cognitive function in rats with type II diabetes mellitus with cognitive impairment;(台灣農業研究67 (4): 355-364) 香菇柄水萃物改善糖尿病降低阿茲海默氏症罹病風險初探;Altered Mineral Metabolism and Disequilibrium Between Calcification Promoters and Inhibitors in Chronic Hemodialysis Patients;Cellular Metabolomics Reveal the Mechanism Underlying the Anti-Atherosclerotic Effects of Aspirin Eugenol Ester on Vascular Endothelial Dysfunction;Fushiming Capsule Attenuates Diabetic Rat Retina Damage via Antioxidation and Anti-Inflammation;Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease;Supplementation with Korean Red Ginseng Improves Current Perception Threshold in Korean Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo …;A New Insight into Meloxicam: Assessment of Antioxidant and Anti-Glycating Activity in In Vitro Studies;Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1α/PDK4 pathway;The effect of Korean Red Ginseng on sarcopenia biomarkers in type 2 diabetes patients;The Role of PPARγ in Hyperglycemia-induced Deleterious Effect on Chondrocytes;Young and Undamaged rMSA Improves the Healthspan and Lifespan of Mice;Dietary Advanced Glycation End Products Shift the Gut Microbiota Composition and Induce Insulin Resistance in Mice;